FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

23714911000001101: Trastuzumab emtansine (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2014. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    77392501000001119 Trastuzumab emtansine (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    77392601000001115 Trastuzumab emtansine en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Trastuzumab emtansine Is a Cytotoxic false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Trastuzumab emtansine 100mg powder for solution for infusion vials Has specific active ingredient False Trastuzumab emtansine Inferred relationship Existential restriction modifier
    Trastuzumab emtansine 160mg powder for solution for infusion vials Has specific active ingredient False Trastuzumab emtansine Inferred relationship Existential restriction modifier
    Kadcyla 100mg powder for concentrate for solution for infusion vials (Roche Products Ltd) Has specific active ingredient False Trastuzumab emtansine Inferred relationship Existential restriction modifier
    Kadcyla 160mg powder for concentrate for solution for infusion vials (Roche Products Ltd) Has specific active ingredient False Trastuzumab emtansine Inferred relationship Existential restriction modifier
    Trastuzumab emtansine 160mg powder for solution for infusion vials 1 vial Has specific active ingredient False Trastuzumab emtansine Inferred relationship Existential restriction modifier
    Trastuzumab emtansine 100mg powder for solution for infusion vials 1 vial Has specific active ingredient False Trastuzumab emtansine Inferred relationship Existential restriction modifier
    Kadcyla 100mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial Has specific active ingredient False Trastuzumab emtansine Inferred relationship Existential restriction modifier
    Kadcyla 160mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial Has specific active ingredient False Trastuzumab emtansine Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start